Skip to main content
. Author manuscript; available in PMC: 2013 Dec 9.
Published in final edited form as: Genet Epidemiol. 2013 May 5;37(5):10.1002/gepi.21728. doi: 10.1002/gepi.21728

Table D.

6 among 37 pathways are significant with either WKS-Variant or Direct-SKAT pathway level analysis (significance level = 0.05). These 6 pathways each includes at least one of 4 genes in Table C. Pathways are accompanied with their p-values with WKS-Variant and Direct-SKAT methods. At last line of table, we combine all 4 genes in one gene-set.

Pathway Source Description Gene Number Within Gene Number in Table C p-value (WKS-Va riant) p-value (Direct-S KAT)
erythPathway BIOCARTA Erythrocyte Differentiation Pathway 12 2 0.0476 0.3301
hsa04620 KEGG Toll-like receptor signaling pathway 58 1 0.4419 0.0278
hsa04630 KEGG Jak-STAT signaling pathway 99 2 0.4923 0.0064
hsa05210 KEGG Colorectal cancer 53 1 0.3863 0.0078
hsa05211 KEGG Renal cell carcinoma 35 1 0.2622 0.0276
hsa05220 KEGG Chronic myeloid leukemia 44 1 0.2032 0.0062
--- Table C Combine all 4 genes in Table C 4 4 0.0010 0.2932